Company registration number 07546674 (England and Wales)
DATA SCIENCES UK (MN) LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
DATA SCIENCES UK (MN) LIMITED
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 7
DATA SCIENCES UK (MN) LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Current assets
Debtors
4
42,680
39,520
Cash at bank and in hand
58,049
52,584
100,729
92,104
Creditors: amounts falling due within one year
5
(23,267)
(25,153)
Net current assets
77,462
66,951
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
77,362
66,851
Total equity
77,462
66,951

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 15 September 2025 and are signed on its behalf by:
J Eyles
Director
Company registration number 07546674 (England and Wales)
DATA SCIENCES UK (MN) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
1
Accounting policies
Company information

Data Sciences UK (MN) Limited is a private company limited by shares incorporated in England and Wales. The registered office is 2 Southport Road, Chorley, Lancashire, PR7 1LB.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. T he company has therefore taken advantage of e xemptions from the following disclosure requirements:

- Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;

- Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues’: Interest income/expense and net gains/losses for each category of financial instrument; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;

- Section 26 ‘Share based Payment’: Share-based payment expense charged to profit or loss, reconciliation of opening and closing number and weighted average exercise price of share options, how the fair value of options granted was measured, measurement and carrying amount of liabilities for cash-settled share-based payments, explanation of modifications to arrangements;

- Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.

The financial statements of the company are consolidated in the financial statements of Harvard Biosciences Inc. These consolidated financial statements are available from its registered office, 84 October Hill Road, Holliston, Massachusetts 01746, USA.

DATA SCIENCES UK (MN) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 3 -
1.2
Going concern

These financial statements are prepared on the going concern basis. The directors have a reasonable expectation that the company will continue in operational existence for the foreseeable future. However, the directors are aware of certain material uncertainties which may cause doubt on the company's ability to continue as a going concern.

As part of the going concern assessment ,the directors made enquiries of Harvard Biosciences Inc..The Company has obtained a letter of financial support from the immediate and ultimate parent,Harvard Biosciences Inc..The provision of financial support to the company is conditional on the parent company successfully refinancing its outstanding debt by 5 December 2025 to avoid default under its credit agreement. There is no guarantee that such refinancing will be achieved on commercially acceptable terms or within the necessary timeframe. If unsuccessful the parent may not be able to fulfil its commitment to support the Company. As such,this dependency gives rise to a material uncertainty that may cast significant doubt on the company's ability to continue as a going concern.

Despite this the directors believe that the financial statements should be prepared on a going concern basis and do not include any adjustments that would be required should the company be unable to continue as a going concern.

1.3
Turnover
Turnover represents amounts receivable on a cost plus basis of charging fees net of VAT and trade discounts.The company also charges for use of their personnel.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

DATA SCIENCES UK (MN) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 4 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

DATA SCIENCES UK (MN) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 5 -
1.7
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.8
Retirement benefits
The company operates a defined contribution scheme for the benefit of its employees.This scheme is organised completely independently from the company. Contributions payable are charged to the profit and loss account in the year they are payable.
1.9
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

1.10
Foreign exchange
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All differences are taken to profit and loss account.The company uses sterling in all its transactions with its US parent company.
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
4
5
DATA SCIENCES UK (MN) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 6 -
4
Debtors
2024
2023
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
41,287
38,379
Other debtors
1,393
1,141
42,680
39,520
5
Creditors: amounts falling due within one year
2024
2023
£
£
Corporation tax
4,047
5,686
Other creditors
19,220
19,467
23,267
25,153
6
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

We draw attention to note 1.2 in the financial statements,which indicates that the company has obtained a letter of financial support from the immediate and ultimate parent,Harvard Biosciences Inc..The provision of financial support to the company is conditional on the parent company successfully refinancing its outstanding debt by 5 December 2025 to avoid default under its credit agreement. There is no guarantee that such refinancing will be achieved on commercially acceptable terms or within the necessary timeframe. As stated in note 1.2,these events and conditions ,indicate a material uncertainty exists that may cast significant doubt on the company's ability to continue as a going concern. Our opinion is not modified in respect of this matter.

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Opinion

In our opinion the financial statements:

- give a true and fair view of the state of the company's affairs as at 31 December 2024 and of its profit for the year then ended;

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- have been prepared in accordance with the requirements of the Companies Act 2006.

Senior Statutory Auditor:
Kieran Brophy ACA
Statutory Auditor:
Smith & Goulding Limited
Date of audit report:
15 September 2025
DATA SCIENCES UK (MN) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 7 -
7
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2024
2023
£
£
Total commitments
21,023
11,459
8
Parent company

The parent company changed during the year from Data Sciences International Inc., a company incorporated in the United States of America owning 100% of the share capital. It was r egistered at 119 14th Street NW,Suite 100,St Paul ,Minnesota.55112,U.S.A.On 23 August 2024 100% of the shares were transferred from Data Sciences International Inc to Harvard Biosciences Inc.

The ultimate controlling party a nd now parent is Harvard Biosciences Inc, a company registered at 84 October Hill Road, Suite 10, Holliston MA 01746-1371.

2024-12-31 2024-01-01 false false false 15 September 2025 CCH Software CCH Accounts Production 2025.100 No description of principal activity J Eyles J Green M Rossi 07546674 2024-01-01 2024-12-31 07546674 2024-12-31 07546674 2023-12-31 07546674 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 07546674 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 07546674 core:ShareCapital 2024-12-31 07546674 core:ShareCapital 2023-12-31 07546674 core:RetainedEarningsAccumulatedLosses 2024-12-31 07546674 core:RetainedEarningsAccumulatedLosses 2023-12-31 07546674 bus:Director1 2024-01-01 2024-12-31 07546674 2023-01-01 2023-12-31 07546674 core:CurrentFinancialInstruments 2023-12-31 07546674 core:WithinOneYear 2024-12-31 07546674 core:WithinOneYear 2023-12-31 07546674 core:CurrentFinancialInstruments 2024-12-31 07546674 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 07546674 bus:FRS102 2024-01-01 2024-12-31 07546674 bus:Audited 2024-01-01 2024-12-31 07546674 bus:Director2 2024-01-01 2024-12-31 07546674 bus:Director3 2024-01-01 2024-12-31 07546674 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 07546674 bus:FullAccounts 2024-01-01 2024-12-31 xbrli:pure xbrli:shares iso4217:GBP